Vahanian & Associates Financial Planning Inc. Athersys, Inc Transaction History

Vahanian & Associates Financial Planning Inc.

  • $24.5 Million
  • Q4 2023

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 27, 2022
BUY
$0.18 - $0.86 $272,277 - $1.3 Million
1,512,655 Added 39.07%
5,384,257 $1.4 Million
Q1 2022

Apr 27, 2022
SELL
$0.6 - $1.06 $750,648 - $1.33 Million
-1,251,080 Reduced 24.42%
3,871,602 $2.34 Million
Q4 2021

Jan 28, 2022
BUY
$0.85 - $1.4 $4.35 Million - $7.17 Million
5,122,682 New
5,122,682 $4.62 Million

About ATHERSYS, INC

ATHX Quotes by TradingView
  • Ticker ATHX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 305,110,016
  • Market Cap $3.05M
  • Description
  • Athersys, Inc., a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. Its clinical development programs are focused on treating neurological conditions, cardiovascular diseases, inflammatory and immune disorders, and pulmonary and other conditions. The company's lead platform product i...
More about ATHX
Track This Portfolio

Track Vahanian & Associates Financial Planning Inc. Portfolio

Follow Vahanian & Associates Financial Planning Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vahanian & Associates Financial Planning Inc., based on Form 13F filings with the SEC.

News

Stay updated on Vahanian & Associates Financial Planning Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email